Stevens-Johnson综合征眼睑相关角膜病变的自然病程与治疗干预影响
该回顾性对比病例系列纳入401例SJS慢性眼睑相关角膜病变患者的705眼,比较保守治疗与确定性治疗(MMG、PROSE或两者联合)的长期视力结局。保守治疗者10年内中位BCVA至少下降5行,且第一年角膜溃疡风险高3倍;确定性治疗显著改善BCVA,儿童中MMG优于PROSE,成人中PROSE优于MMG,两者联合效果最佳。
要点
- 保守治疗者10年内中位BCVA至少下降5行,第一年角膜溃疡风险高3倍。
- 确定性治疗显著改善中位BCVA(P < .0001)。
- 儿童中MMG优于PROSE(P = .009),成人中PROSE优于MMG(P = .028)。
核心结论
- MMG和PROSE均改变SJS眼睑相关角膜病变的自然病程,有助于保持和改善视力。
- 无论年龄,接受MMG和PROSE联合治疗者长期视力结局最佳。
研究设计与样本
- 回顾性对比病例系列,纳入1990至2015年间401例SJS慢性眼睑相关角膜病变患者的705眼,其中儿童81例、成人320例。
- 患眼接受保守治疗(局部药物,n = 363)或确定性治疗(n = 342),后者包括MMG、PROSE或两者联合。
主要发现
- 保守治疗组儿童和成人10年内中位BCVA至少下降5行,第一年角膜溃疡风险高3倍。
- 确定性治疗显著改善中位BCVA(P < .0001)。
- 儿童中MMG比PROSE更有效(P = .009),成人中PROSE比MMG更有效(P = .028)。
- MMG后联合PROSE在儿童和成人中均效果最佳(P < .036)。
关键数值与推荐
- 主要结局为最佳矫正视力(BCVA)随时间的变化,次要结局为第一年发生角膜溃疡或穿孔的比值比。
- 治疗亚组基线BCVA和既往治疗可比(P > .10)。
临床怎么用
- 对SJS慢性眼睑相关角膜病变,应积极考虑MMG或PROSE等确定性治疗以改变自然病程。
- 儿童可优先考虑MMG,成人可优先考虑PROSE,两者联合可能获得最佳长期视力结局。
局限性
- 回顾性研究设计可能引入选择偏倚。
- 原文未报告具体局限性描述。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To compare the long-term visual outcomes of different management strategies in children and adults with Stevens-Johnson Syndrome (SJS)-induced chronic lid-related keratopathy. DESIGN: Retrospective comparative case series. METHODS: This study included 705 eyes of 401 patients (81 children and 320 adults) with SJS who presented with chronic lid-related keratopathy between 1990 and 2015. Affected eyes received either conservative therapy [topical medications (n = 363)] or definitive management (n = 342) that included mucous membrane grafting (MMG), prosthetic replacement of the ocular surface ecosystem (PROSE) contact lenses, or both. The primary outcome measure was change in best corrected visual acuity (BCVA) over time. The secondary outcome measure was the odds of developing corneal ulceration or perforation in the first year. RESULTS: The treatment subgroups were comparable at baseline in terms of BCVA and previous management (P > .10). Over 10 years, children and adults who received conservative therapy lost at least 5 lines of median BCVA and carried a 3 times higher risk of developing corneal ulceration in the first year. Conversely, definitive therapy provided significant benefit by improving median BCVA (P < .0001). In children, MMG was more effective than PROSE (P = .009), whereas PROSE was more effective than MMG in adults (P = .028). However, the combination of MMG followed by PROSE provided the best results in both children and adults (P < .036). CONCLUSIONS: Both MMG and PROSE changed the natural course and helped in preserving and improving vision in eyes with SJS-induced lid-related keratopathy. Regardless of age, those who received both MMG and PROSE had the best long-term visual outcomes.
引用
- Shanbhag SS, Shah S, Singh M, et al. Lid-Related Keratopathy in Stevens-Johnson Syndrome: Natural Course and Impact of Therapeutic Interventions in Children and Adults. Am J Ophthalmol. 2020. PMID: 32681905. doi:10.1016/j.ajo.2020.07.006
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。